• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常肝脏和纤维化肝脏中的库普弗细胞激活通过血栓素A2增加门静脉压力。

Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2).

作者信息

Steib Christian J, Gerbes Alexander L, Bystron Markus, Op den Winkel Mark, Härtl Josef, Roggel Frigga, Prüfer Thomas, Göke Burkhard, Bilzer Manfred

机构信息

Department of Medicine II, Klinikum Grosshadern, Ludwig-Maximilians University, Marchioninistrasse 15, 81366 Munich, Germany.

出版信息

J Hepatol. 2007 Aug;47(2):228-38. doi: 10.1016/j.jhep.2007.03.019. Epub 2007 Apr 9.

DOI:10.1016/j.jhep.2007.03.019
PMID:17573142
Abstract

BACKGROUND/AIMS: Cirrhotic patients show an increased risk of variceal bleeding upon bacterial infections. Kupffer cells (KC) constitute the first macrophage population to become activated by bacterial beta-glucans and endotoxins derived from the gut. We therefore investigated whether and how KC activation increases portal pressure.

METHODS

KC in normal and fibrotic livers from bile duct ligated (BDL) rats were activated by the beta-glucan component of zymosan in vivo and during isolated rat liver perfusion.

RESULTS

Activation of KC in normal livers resulted in a severalfold increase of portal pressure in vivo as well as in isolated perfused liver preparations. This increase and the accompanying 40-fold stimulation of hepatic prostaglandin F(2alpha)/D(2) and thromboxane A(2) (TxA(2)) production in isolated perfused livers were attenuated by KC blockade. The TxA(2) synthase inhibitor furegrelate and the TxA(2) receptor antagonist BM 13.177 reduced the increase of portal perfusion pressure supporting TxA(2) as pivotal vasoconstrictor released by activated KC. Importantly, a more pronounced vasopressor response in fibrotic livers was related to a raise in KC density and a 10-fold increase of TxA(2) production after KC activation.

CONCLUSIONS

KC activated by beta-glucans increase portal pressure through the release of TxA(2). This vasopressor response is augmented in BDL induced fibrosis.

摘要

背景/目的:肝硬化患者在发生细菌感染时静脉曲张出血风险增加。库普弗细胞(KC)是首个被肠道来源的细菌β-葡聚糖和内毒素激活的巨噬细胞群体。因此,我们研究了KC激活是否以及如何增加门静脉压力。

方法

通过酵母聚糖的β-葡聚糖成分在体内及离体大鼠肝脏灌注过程中激活胆管结扎(BDL)大鼠正常肝脏和纤维化肝脏中的KC。

结果

正常肝脏中KC的激活导致体内以及离体灌注肝脏标本中门静脉压力增加数倍。KC阻断可减弱这种增加以及离体灌注肝脏中伴随的肝前列腺素F(2α)/D(2)和血栓素A(2)(TxA(2))产生的40倍刺激。TxA(2)合酶抑制剂呋格雷酯和TxA(2)受体拮抗剂BM 13.177降低了门静脉灌注压力的增加,支持TxA(2)作为激活的KC释放的关键血管收缩剂。重要的是,纤维化肝脏中更明显的升压反应与KC密度增加以及KC激活后TxA(2)产生增加10倍有关。

结论

β-葡聚糖激活的KC通过释放TxA(2)增加门静脉压力。这种升压反应在BDL诱导的纤维化中增强。

相似文献

1
Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2).正常肝脏和纤维化肝脏中的库普弗细胞激活通过血栓素A2增加门静脉压力。
J Hepatol. 2007 Aug;47(2):228-38. doi: 10.1016/j.jhep.2007.03.019. Epub 2007 Apr 9.
2
Role of thromboxane A2 in early BDL-induced portal hypertension.血栓素A2在早期胆管结扎诱导的门静脉高压中的作用。
Am J Physiol Gastrointest Liver Physiol. 2003 Mar;284(3):G453-60. doi: 10.1152/ajpgi.00315.2002. Epub 2002 Nov 13.
3
Amiloride reduces portal hypertension in rat liver cirrhosis.阿米洛利可降低肝硬化大鼠的门静脉高压。
Gut. 2010 Jun;59(6):827-36. doi: 10.1136/gut.2009.197756.
4
Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis.用白三烯抑制剂孟鲁司特治疗 10 天可减轻大鼠肝硬化门静脉高压。
Hepatology. 2010 Jun;51(6):2086-96. doi: 10.1002/hep.23596.
5
Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis.枯否细胞耗竭可减轻肥胖型非酒精性脂肪性肝炎-肝硬化大鼠模型中介导甲氧胺刺激门脉灌注压和血栓素 A2 释放的瘦素作用。
Clin Sci (Lond). 2012 Dec;123(12):669-80. doi: 10.1042/CS20110572.
6
Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers.肝血窦内皮细胞产生的血管收缩性前列腺素增加,会导致肝硬化大鼠肝脏的门静脉灌注压升高。
J Hepatol. 2007 Aug;47(2):220-7. doi: 10.1016/j.jhep.2007.03.014. Epub 2007 Apr 5.
7
Kupffer cell activation by hydrogen peroxide: a new mechanism of portal pressure increase.过氧化氢诱导枯否细胞激活:门静脉高压形成的新机制。
Shock. 2010 Apr;33(4):412-8. doi: 10.1097/SHK.0b013e3181b85934.
8
Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.环氧化酶衍生产物调节肝硬化大鼠肝脏肝内阻力增加的情况。
Hepatology. 2003 Jan;37(1):172-81. doi: 10.1053/jhep.2003.50004.
9
LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver.脂多糖加剧内皮素-1诱导的前纤维化大鼠肝脏库普弗细胞胞质磷脂酶A2的激活及血栓素A2的生成。
J Hepatol. 2007 Feb;46(2):276-85. doi: 10.1016/j.jhep.2006.08.026. Epub 2006 Nov 29.
10
Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.窦状隙内皮细胞中COX-1衍生的前列腺素调节肝硬化大鼠肝脏的肝血管张力。
Am J Physiol Gastrointest Liver Physiol. 2005 Apr;288(4):G763-70. doi: 10.1152/ajpgi.00300.2004. Epub 2004 Nov 18.

引用本文的文献

1
Sex-specific differences in preclinical models of advanced chronic liver disease and portal hypertension.晚期慢性肝病和门静脉高压症临床前模型中的性别差异。
Biol Sex Differ. 2025 Jun 3;16(1):39. doi: 10.1186/s13293-025-00721-8.
2
Gram-negative bacteria-driven increase of cytosolic phospholipase A2 leads to activation of Kupffer cells.革兰氏阴性菌驱动的胞质磷脂酶A2增加导致库普弗细胞活化。
Cell Mol Life Sci. 2024 Dec 27;82(1):22. doi: 10.1007/s00018-024-05451-5.
3
Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut-Liver Axis.
肠-肝轴中免疫屏障失调相关 ROS 凋亡机制下内毒素对细胞的炎症作用。
Int J Mol Sci. 2024 Feb 20;25(5):2472. doi: 10.3390/ijms25052472.
4
Intravoxel incoherent motion diffusion-weighted imaging for evaluating the pancreatic perfusion in cirrhotic patients.体素内不相干运动扩散加权成像评估肝硬化患者胰腺灌注。
Abdom Radiol (NY). 2024 Feb;49(2):492-500. doi: 10.1007/s00261-023-04063-0. Epub 2023 Dec 5.
5
Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity.肝硬化时肾上腺素能阻滞剂的神经免疫调节:肝星状细胞活性的调节。
Ann Med. 2023 Dec;55(1):543-557. doi: 10.1080/07853890.2022.2164047.
6
Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development.二十碳类化合物及其他氧化脂质在肝损伤、炎症和肝癌发生中的作用
Front Physiol. 2023 Feb 2;14:1098467. doi: 10.3389/fphys.2023.1098467. eCollection 2023.
7
Kinin B1 receptor blockade attenuates hepatic fibrosis and portal hypertension in chronic liver diseases in mice.缓激肽 B1 受体阻断剂可减轻慢性肝病小鼠的肝纤维化和门静脉高压。
J Transl Med. 2022 Dec 13;20(1):590. doi: 10.1186/s12967-022-03808-7.
8
Soluble CD163 for Prediction of High-Risk Esophageal Varices and Variceal Hemorrhage in Patients with Liver Cirrhosis.可溶性CD163用于预测肝硬化患者的高危食管静脉曲张和静脉曲张出血
GE Port J Gastroenterol. 2021 Jul 27;29(2):82-95. doi: 10.1159/000516913. eCollection 2022 Mar.
9
A novel prostaglandin I agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice.一种新型前列腺素I激动剂ONO-1301可减轻非酒精性脂肪性肝炎模型小鼠的肝脏炎症并抑制纤维化。
Inflamm Regen. 2022 Feb 1;42(1):3. doi: 10.1186/s41232-021-00191-6.
10
Review article: therapeutic aspects of bile acid signalling in the gut-liver axis.综述文章:肠道-肝脏轴中胆汁酸信号转导的治疗作用。
Aliment Pharmacol Ther. 2021 Nov;54(10):1243-1262. doi: 10.1111/apt.16602. Epub 2021 Sep 23.